Pacer Advisors Inc. Buys Shares of 513,152 Astera Labs, Inc. $ALAB

Pacer Advisors Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the third quarter, HoldingsChannel.com reports. The firm bought 513,152 shares of the company’s stock, valued at approximately $100,475,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Oliver Lagore Vanvalin Investment Group bought a new position in Astera Labs during the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs in the second quarter valued at approximately $36,000. Clearstead Trust LLC raised its holdings in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the period. Advisors Asset Management Inc. boosted its position in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after purchasing an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC grew its holdings in shares of Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after buying an additional 283 shares during the period. 60.47% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. This trade represents a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 586,936 shares of company stock valued at $89,331,140 over the last 90 days. 12.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on ALAB shares. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Cowen reiterated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Barclays restated an “equal weight” rating and set a $155.00 target price on shares of Astera Labs in a report on Monday, October 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $188.17.

Get Our Latest Stock Analysis on ALAB

Astera Labs Stock Performance

NASDAQ:ALAB opened at $169.81 on Friday. The company has a market cap of $28.68 billion, a PE ratio of 152.98, a PEG ratio of 3.17 and a beta of 1.51. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The stock has a 50-day simple moving average of $159.62 and a 200 day simple moving average of $157.21.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the previous year, the business posted $0.23 EPS. The business’s quarterly revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.